These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8491609)

  • 1. Re: Probability of causation.
    Jose DE
    Health Phys; 1993 May; 64(5):549-50. PubMed ID: 8491609
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical viewpoint on NCRP probability of causation statement.
    Gray JE
    Health Phys; 1993 May; 64(5):550-1. PubMed ID: 8491610
    [No Abstract]   [Full Text] [Related]  

  • 3. Reflections on NCRP Statement No. 7.
    Saenger EL
    Health Phys; 1993 May; 64(5):549. PubMed ID: 8491608
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications of claimant-favorable approaches used in dose and probability of causation calculations under EEOICPA.
    Merwin SE; Stewart DN; Smith MH; Potter KD; Hinnefeld SL
    Health Phys; 2008 Jul; 95(1):148-59. PubMed ID: 18545037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electromagnetic fields: is there any probability of the risk of cancer?].
    Davydov BI; Zuev VG; Obukhova SB
    Aviakosm Ekolog Med; 2003; 37(2):16-9. PubMed ID: 12722420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARCINOMA OF THYROID IN CHILDREN: RELATION TO PREVIOUS IRRADIATION.
    RACHMANINOFF N
    Harper Hosp Bull; 1963; 21():166-71. PubMed ID: 14055889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basis of radiation protection].
    Roth J; Schweizer P; Gückel C
    Schweiz Med Wochenschr; 1996 Jun; 126(26):1157-71. PubMed ID: 8711464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On physicalism and downward causation in developmental and cancer biology.
    Soto AM; Sonnenschein C; Miquel PA
    Acta Biotheor; 2008 Dec; 56(4):257-74. PubMed ID: 18542843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pre-emptive re-transplant in graft and recipient outcome.
    Goldfarb-Rumyantzev AS; Hurdle JF; Baird BC; Stoddard G; Wang Z; Scandling JD; Barenbaum LL; Cheung AK
    Nephrol Dial Transplant; 2006 May; 21(5):1355-64. PubMed ID: 16476722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variance estimators for three "probabilities of causation".
    Cai Z; Kuroki M
    Risk Anal; 2005 Dec; 25(6):1611-20. PubMed ID: 16506987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoma and mitogenetic radiation; seen from the viewpoint of dysoxibiosis].
    SEEGER PG
    Med Monatsschr; 1952 Aug; 6(8):489-93. PubMed ID: 12992469
    [No Abstract]   [Full Text] [Related]  

  • 12. A weight of evidence approach to causal inference.
    Swaen G; van Amelsvoort L
    J Clin Epidemiol; 2009 Mar; 62(3):270-7. PubMed ID: 18834711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predominance of the environment over genes in cancer causation: implications for genetic epidemiology.
    Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1037-9. PubMed ID: 15894649
    [No Abstract]   [Full Text] [Related]  

  • 14. A numerical solution to the nonhomogeneous two-stage MVK model of cancer.
    Crump KS; Subramaniam RP; Van Landingham CB
    Risk Anal; 2005 Aug; 25(4):921-6. PubMed ID: 16268939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.
    Lippman SM; Hong WK
    Clin Cancer Res; 2002 Feb; 8(2):305-13. PubMed ID: 11839646
    [No Abstract]   [Full Text] [Related]  

  • 16. [Environmental and hereditary factors in the causation of cancer].
    Bonaït-Pellié C
    Rev Epidemiol Sante Publique; 2000 Dec; 48(6):589-90. PubMed ID: 11386211
    [No Abstract]   [Full Text] [Related]  

  • 17. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for a new tool to evaluate drug interaction cases.
    Horn JR; Hansten PD; Chan LN
    Ann Pharmacother; 2007 Apr; 41(4):674-80. PubMed ID: 17389673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
    Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
    Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.